UBS Group Analysts Give Brenntag (BNR) a €52.50 Price Target

Share on StockTwits

UBS Group set a €52.50 ($61.05) price target on Brenntag (FRA:BNR) in a research report sent to investors on Monday morning, www.boersen-zeitung.de reports. The brokerage currently has a buy rating on the stock.

Other equities analysts also recently issued reports about the stock. Baader Bank set a €62.00 ($72.09) target price on shares of Brenntag and gave the stock a buy rating in a research note on Wednesday, November 7th. Commerzbank set a €61.00 ($70.93) target price on shares of Brenntag and gave the stock a buy rating in a research note on Wednesday, November 7th. equinet set a €59.80 ($69.53) target price on shares of Brenntag and gave the stock a buy rating in a research note on Wednesday, November 7th. Kepler Capital Markets set a €63.00 ($73.26) target price on shares of Brenntag and gave the stock a buy rating in a research note on Wednesday, November 7th. Finally, Jefferies Financial Group set a €61.00 ($70.93) target price on shares of Brenntag and gave the stock a buy rating in a research note on Thursday, November 8th. Five research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. The stock has an average rating of Buy and a consensus price target of €52.83 ($61.43).

Shares of FRA BNR opened at €44.04 ($51.21) on Monday. Brenntag has a 1-year low of €43.06 ($50.07) and a 1-year high of €56.25 ($65.41).

Brenntag Company Profile

Brenntag AG, a chemical distribution company, purchases and supplies industrial and specialty chemicals in Europe, the Middle East, Africa, North America, Latin America, the Asia Pacific, and internationally. The company also provides value added services. It serves customers in various end-market industries, such as adhesives, paints, oil and gas, food, water treatment, personal care, and pharmaceuticals.

Featured Story: What is a Lock-Up Period?

Analyst Recommendations for Brenntag (FRA:BNR)

Receive News & Ratings for Brenntag Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brenntag and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

LPL Financial  Cut to Hold at BidaskClub
LPL Financial Cut to Hold at BidaskClub
KEYW  Rating Increased to Buy at BidaskClub
KEYW Rating Increased to Buy at BidaskClub
IAC/InterActiveCorp  Raised to Buy at BidaskClub
IAC/InterActiveCorp Raised to Buy at BidaskClub
Reviewing Guardant Health  & Its Competitors
Reviewing Guardant Health & Its Competitors
Head to Head Comparison: Red Lion Hotels  & Its Rivals
Head to Head Comparison: Red Lion Hotels & Its Rivals
$480.90 Million in Sales Expected for Kraton Corp  This Quarter
$480.90 Million in Sales Expected for Kraton Corp This Quarter


© 2006-2019 Ticker Report